What is the half-life of Fluorine-18 (F-18)?

Fluorine-18 has a half-life of 109.8 minutes. It is used in FDG and Pylarify for PET imaging and requires tungsten syringe shielding to reduce technologist exposure.

Which isotope is used in Pluvicto and Lutathera?

Lutetium-177 (Lu-177) is used in both Pluvicto (prostate cancer) and Lutathera (neuroendocrine tumors). It has a 6.7-day half-life and emits beta particles for therapy and gamma photons for imaging.

What are common PET imaging isotopes besides F-18?

Gallium-68 (Ga-68) for NET and PSMA imaging, and Copper-64 (Cu-64) for neuroendocrine imaging. Ga-68 has a 67.7-minute half-life; Cu-64 has a 12.7-hour half-life.

Why does Radium-223 (Xofigo) require strict contamination control?

Ra-223 decays by alpha emission. Alpha particles have very short range, so external exposure is low, but internal exposure must be avoided through proper handling, PPE, and contamination surveys.

Understanding Common Isotopes in PET & Radiopharmaceutical Therapy

Topic Explanation: Why Isotope Physics Matters in PET and RPT

Modern nuclear medicine relies on carefully selected radionuclides for both diagnostic imaging and targeted therapy. Each isotope has unique physical characteristics—half-life, emission type, and radiation energy—that directly affect image quality, patient management, staff exposure, and radiation safety procedures.

Understanding these isotopes helps technologists optimize workflow, ensure regulatory compliance, and minimize occupational exposure while delivering safe and effective patient care.

Common PET Imaging Isotopes

Fluorine-18 (F-18) – FDG, Pylarify

Half-life: 109.8 minutes
Decay mode: Positron emission → 511 keV annihilation photons
Clinical use:
- FDG: Oncology, neurology, infection imaging
- Pylarify (piflufolastat F-18): Prostate cancer imaging

Physics and Safety Considerations: F-18 provides excellent image quality due to its short positron range and manageable half-life. However, its high-energy annihilation photons require proper syringe shielding, typically tungsten, to reduce technologist exposure during dose handling and injection.

Gallium-68 (Ga-68) – NETSPOT, Locametz

Half-life: 67.7 minutes
Decay mode: Positron emission
Clinical use: Neuroendocrine tumor imaging (NETs), PSMA imaging

Physics and Safety Considerations:

Ga-68's shorter half-life allows rapid decay but requires precise coordination between preparation and imaging. It is often produced using a generator, making it accessible without a cyclotron. Radiation exposure decreases quickly due to rapid decay.

Copper-64 (Cu-64) – Detectnet

Half-life: 12.7 hours
Decay mode: Positron emission and beta decay
Clinical use: Neuroendocrine tumor imaging

Physics and Safety Considerations:

Cu-64's longer half-life allows centralized production and flexible scheduling. However, waste and contaminated materials remain radioactive longer and must follow proper decay-in-storage procedures.

Common Radiopharmaceutical Therapy (RPT) Isotopes

Lutetium-177 (Lu-177) – Lutathera, Pluvicto

Half-life: 6.7 days
Decay mode: Beta emission with gamma emissions
Clinical use:
- Lutathera: Neuroendocrine tumors
- Pluvicto: Prostate cancer

Physics and Safety Considerations:

Lu-177 emits beta particles for therapy and gamma photons that allow imaging and dosimetry. Because patients remain radioactive for several days, technologists must minimize close contact time and follow proper radiation safety protocols.

Radium-223 (Ra-223) – Xofigo

Half-life: 11.4 days
Decay mode: Alpha emission
Clinical use: Treatment of bone metastases in prostate cancer

Physics and Safety Considerations:

Alpha particles have extremely high energy but very short range. External exposure risk is low, but contamination control is critical. Internal exposure must be avoided through proper handling, PPE use, and contamination surveys.

Key Physics and Radiation Safety Principles

Shielding Requirements

Different radiation types require different shielding approaches:

Positron emitters (F-18, Ga-68, Cu-64): Tungsten or lead syringe shields
Beta emitters (Lu-177): Acrylic shielding to reduce bremsstrahlung production
Alpha emitters (Ra-223): Focus on contamination control rather than external shielding

Contamination Prevention

Technologists should:

Use syringe shields during preparation and administration
Use absorbent pads during injection
Perform routine contamination surveys
Follow proper waste handling procedures

Waste Management Considerations

Isotopes with longer half-lives, such as Cu-64 and Lu-177, require decay-in-storage before disposal. Proper labeling, documentation, and storage ensure regulatory compliance and safe handling.

Patient and Staff Protection

Radiation exposure can be minimized using the three core ALARA principles:

Minimize time near radioactive patients
Maximize distance whenever possible
Use appropriate shielding

Technologists play a critical role in maintaining these protections during imaging and therapy procedures.

Conclusion

Each PET and therapeutic isotope has unique physical properties that directly influence imaging performance, radiation exposure, and safety protocols. Understanding isotope half-life, emission type, and clinical application allows technologists to optimize procedures, protect themselves and others, and ensure safe and effective patient care. As radiopharmaceutical therapy continues to expand, isotope knowledge remains essential to modern nuclear medicine practice.